HOME >> MEDICINE >> NEWS
ReQuip cuts risk of dyskinesias by 15-fold in early Parkinson's disease

Vancouver, Canada - A landmark, multinational, 5-year study shows that the dopamine-agonist ReQuip® (ropinirole hydrochloride, SmithKline Beecham) is associated with a much lower incidence of dyskinesias than L-dopa, and has comparable efficacy to L-dopa in the management of early Parkinson's Disease. The results of this exciting study are released today for the first time at the XIII International Congress on Parkinson's Disease (ICPD), Vancouver, 24-28 July, 1999.

"This landmark study should affect the future management of Parkinson's Disease. The data demonstrate that ropinirole is a first-line option for the initial treatment of early Parkinson's Disease," commented lead author of the study, Professor Olivier Rascol, Professor of Pharmacology at the Centre Hospitalier Universitaire, Toulouse, France.

"This is important news for patients, as we can now hope for good control of their symptoms with less risk of dyskinesias," concluded Dr Donald Calne, Chairman of the ICPD, and Director of the Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, Canada.

The 268 patients participating in this double-blind controlled study, conducted in Europe, Israel and Canada, were randomised to receive either ReQuip® or L-dopa -- the current standard therapy. Both treatment groups were allowed to receive supplementary L-dopa if required.

The study demonstrated that the probability (odds ratio) of developing dyskinesias was 3.8 times higher for patients receiving L-dopa (incidence 46%) than for patients receiving ReQuip®, either alone or with additional L-dopa (incidence 20%). In patients who completed the trial on ReQuip® alone, the benefit was found to be even greater, with the relative probability of dyskinesias 15.2 times higher in the L-dopa group (incidence 36%) than the ReQuip® group (incidence 5%).

Over the 5-year study period, both groups of patients experienced similar control of their symptoms. A
'"/>

Contact: Kate Davies (Vancouver)
alexa@meditech.co.uk
44-780-840-345
MediTech Media Ltd.
26-Jul-1999


Page: 1 2

Related medicine news :

1. Clozapine effective for controlling dyskinesias in people with severe Parkinsons
2. New marker for early diagnosis of kidney failure identified
3. English-speaking Hispanic youth more likely to have sex early
4. Inpatient smoking cessation counseling is associated with early differences in mortality
5. Study finds no reason for expectant mothers to shy away from early epidurals
6. No increase in C-sections when epidural analgesia given early in labor
7. Radiologists offer non-surgical treatment for early-stage liver cancer
8. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
9. A new method for early detection of disease outbreaks
10. UCLA study: Nearly a third of drug ads in medical journals contain no references for medical claims
11. Morbidly obese pay nearly twice as much for health care

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2018)... SAN JOSE, Calif. (PRWEB) , ... December 07, ... ... reputable orthopedic surgeon who serves the San Francisco Bay area with ... in his field, and he recognizes the importance of educating patients on the ...
(Date:12/6/2018)... ... December 06, 2018 , ... HMP, a leader in healthcare ... The meeting will take place May 9–10, 2019, and will be co-located with ... Antonio, Texas. , PACS is uniquely designed to provide nurses with the important ...
(Date:12/5/2018)... Pa. (PRWEB) , ... December 05, 2018 , ... ... New Vitae Wellness and Recovery , has been reappointed to serve on Philadelphia ... creating policies that support inclusion of those who identify with a cognitive or ...
(Date:12/5/2018)... ... December 05, 2018 , ... Marking its seventh year, ... celebration “A Toast Heard ‘Round the World” on New Year’s Eve. Each year ... global community (alumni, students, faculty members, staff, families, and friends of the institution) to ...
(Date:12/5/2018)... ... 2018 , ... Northcentral University (NCU) has today announced the launch of two ... a weekly rolling basis to registered nurses, the Master of Science in Nursing ... will prepare degree candidates to become leaders in the high-demand field. , “In ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... Join the BFE ... is an interdisciplinary biofeedback conference to nurture communication and education between specialists from ... disciplines come together to share and learn. The meeting offers a broad range ...
(Date:12/5/2018)... ... December 05, 2018 , ... NDA Partners Chairman ... Director of Global Laboratory Integration at the United States Pharmacopeial Convention (USP), has ... executive with extensive experience in domestic and international operations harmonization, compendial affairs, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for Health ... launch of the Annatto-E™ product line, containing unique and natural vitamin E tocotrienols ... DFH’s new Annatto-E™ products are available in three dosages of 75mg (with black ...
Breaking Medicine Technology:
Cached News: